title: Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo.
abstract: In this study, DNA damage in tumour cells, as well as irreversible cell damage leading to apoptosis induced in vivo by the combined application of cisplatin and inhalation anaesthetics, was investigated. The genotoxicity of anaesthetics on Ehrlich ascites tumour (EAT) cells of mice, alone or in combined application with cisplatin, was estimated by using the alkaline comet assay. The percentage of EAT cell apoptosis was quantified by flow cytometry. Groups of EAT-bearing mice were (i) treated intraperitoneally with cisplatin, (ii) exposed to repeated anaesthesia with inhalation anaesthetic, and (iii) subjected to combined treatment of exposure to anaesthetics after cisplatin for 3 days. Sevoflurane, halothane and isoflurane caused strong genotoxic effects on tumour cells in vivo. The tested anaesthetics alone showed no direct effect on programmed cell death although sevoflurane and especially halothane decreased the number of living EAT cells in peritoneal cavity lavage. Repeated anaesthesia with isoflurane had stimulatory effects on EAT cell proliferation and inhibited tumour cell apoptosis (6.11%), compared to the control group (10.26%). Cisplatin caused massive apoptosis of EAT cells (41.14%) and decreased the number of living EAT cells in the peritoneal cavity. Combined cisplatin and isoflurane treatment additionally increased EAT cell apoptosis to 51.32%. Combined treatment of mice with cisplatin and all anaesthetics increased the number of living tumour cells in the peritoneal cavity compared to cisplatin treatment of mice alone. These results suggest that the inhalation of anaesthetics may protect tumour cells from the cisplatin-induced genotoxic and cytotoxic effects.
authors.affiliation: Department of Anaesthesiology and ICU, University Hospital for Tumours, Zagreb, Croatia.
authors.forename: Gordana
authors.initials: G
authors.lastname: Brozovic
authors.forename: Nada
authors.initials: N
authors.lastname: Orsolic
authors.forename: Fabijan
authors.initials: F
authors.lastname: Knezevic
authors.forename: Anica
authors.initials: A
authors.lastname: Horvat Knezevic
authors.forename: Vesna
authors.initials: V
authors.lastname: Benkovic
authors.forename: Katarina
authors.initials: K
authors.lastname: Sakic
authors.forename: Zlatko
authors.initials: Z
authors.lastname: Hrgovic
authors.forename: Kreso
authors.initials: K
authors.lastname: Bendelja
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Fassbender
mesh_terms: D018685:Anesthetics, Inhalation / Q000008:administration & dosage*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000473:pathology*; D002945:Cisplatin / Q000008:administration & dosage*; D004249:DNA Damage / Q000187:drug effects*; D004347:Drug Interactions; D008297:Male; D051379:Mice; D016896:Treatment Outcome
chemical_list: D018685:Anesthetics, Inhalation; D002945:Cisplatin